Vimarsana
Biggest News Aggregation in the World

Ahnm J News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ahnm J. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ahnm J Today - Breaking & Trending Today

EU Approval Sought for Encorafenib/Binimetinib in BRAF V600+ Advanced NSCLC - Vimarsana News

EU Approval Sought for Encorafenib/Binimetinib in BRAF V600+ Advanced NSCLC

Published: November 2, 2023

The European Medicines Agency had validated a marketing authorization application seeking the approval of the combination of encorafenib and binimetinib for the treatment of adult patients with BRAF V600–mutant advanced non–small cell lung cancer.

Source: onclive.com
Related Topics:
Eric DucournauPierre Fabre LaboratorieEuropean Medicines AgencyPierre Fabre LaboratoriesMedicines AgencyAhnm J
Datopotamab Deruxtecan Elicits Antitumor Activity in Pretreated NSCLC With Actionable Genomic Alterations - Vimarsana News

Datopotamab Deruxtecan Elicits Antitumor Activity in Pretreated NSCLC With Actionable Genomic Alterations

Published: October 26, 2023

Datopotamab deruxtecan elicited encouraging responses in patients with heavily pretreated non–small cell lung cancer harboring actionable genomic alterations.

Source: onclive.com
Related Topics:
Luis PazLuis Paz AresHospital UniversitanoAhnm JDatopotamab DeruxtecanNon Small Cell Lung Cancer Harboring Actionable Genomic AlterationsTropion Lung05 Trial Hospital Universitano 12 De Octubre